Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

xerostomia/fatigue

Veza se sprema u međuspremnik
Stranica 1 iz 366 rezultatima
OBJECTIVE Fatigue is a common clinical manifestation in patients with primary Sjögren's syndrome (pSS). The aims of this study were to investigate the association between fatigue severity and other clinical characteristics in pSS patients and to determine the factors contributing to

Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Our aim was to evaluate fatigue and quality of life (QoL) in Moroccan patients with primary Sjögren's syndrome (PSS) and determine their correlates with disease-related parameters. Fifty-seven consecutive patients with PSS according to the American-European Consensus group (AEGG) criteria were

Fatigue and its associated factors in hospice cancer patients in Taiwan.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Fatigue is one of the most distressful problems faced by terminally ill cancer patients, but few studies have explored fatigue experiences in this population. The purpose of this descriptive correlational study was to examine fatigue status and its related factors in terminally ill cancer patients

Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND Oral candidiasis (OC) is a potential oral complication in Sjögren's syndrome (SS). Some studies indicate that the low stimulated salivary flow and not low unstimulated salivary flow is associated with OC in SS, while others report that the underlying autoimmune disorders contribute to OC,

Factors influencing dry mouth in patients with primary Sjögren syndrome: usefulness of the ESSPRI index.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE To evaluate health-related quality of life in a large series of primary SS patients using the recently-proposed ESSPRI questionnaire and to evaluate the relationship between the intensity of oral dryness and other signs and symptoms frequently found in these patients. METHODS We evaluated

Pilocarpine used to treat xerostomia in patients submitted to radioactive iodine therapy: a pilot study.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Xerostomia complaint is very commonly associated to radioactive iodine therapy. Alternatives to treat this morbidity can offer better quality of life to patients with thyroid cancer submitted to adjuvant iodine therapy. OBJECTIVE to report on the experience with pilocarpine on the treatment of
BACKGROUND Xerostomia is a chief complaint of patients with Sjögren's syndrome (SS). However, newer proposals for SS classification remove xerostomia and hyposalivation from the criteria list. Given these developments and the importance of patient-centered research outcomes, we sought to evaluate

Adjunctive atomoxetine for residual fatigue in major depressive disorder.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE To assess the effectiveness and safety of atomoxetine as an adjunctive medication for residual fatigue in a naturalistic treatment setting. METHODS A retrospective chart review was conducted to identify major depressive disorder (MDD) patients who had experienced significant symptom
Here we report a case of primary Sjögren's syndrome with hilar lymphadenopathy, interstitial pneumonitis and interstitial tubulo-nephritis. A 60-year old man was admitted to our hospital in May 1993 because of general fatigue and fever. He was noted to have hypergammaglobulinemia and had positive

Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndrome.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE To evaluate the efficacy of the essential omega-6 fatty acid Gammalinolenic acid (GLA) on fatigue associated with primary Sjögren's syndrome. METHODS Ninety patients with primary Sjögren's syndrome (with or without signs of autoimmunity) entered a 6-month double blind placebo-controlled

What's in a Name? Word descriptors of cancer-related fatigue.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Many different words are used to describe fatigue. It is unclear whether these word descriptors represent the same cancer symptom or dimension. The objective of this study was to identify clinical associations of three fatigue word descriptors (FWDs): 'easy fatigue', 'weakness', and 'lack of energy'

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Cancer and its treatment can induce subjective and objective evidence of diminished functional capacity encompassing physical fatigue and cognitive impairment. Dexmethylphenidate (D-MPH; the D-isomer of methylphenidate) was evaluated for treatment of chemotherapy-related fatigue and cognitive
BACKGROUND Metastatic renal cell carcinoma (mRCC) has historically been refractory to cytotoxic and hormonal agents. IL-2 and IFN-α provide response in a minority of patients. Small molecule tyrosine kinase inhibitors and monoclonal antibodies have established a role in the setting of mRCC. However,

Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE To evaluate the efficacy and tolerability of telcagepant when co-administered with ibuprofen or acetaminophen for the acute treatment of migraine. BACKGROUND Telcagepant is an oral calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of

Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND Much has been done to examine the psychological impact of cancer treatment, but it remains unclear to what extent anxiety and depression is related to symptom prevalence. The present study concerned the characteristics and frequency of distress as related to symptom prevalence in cancer
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge